跳至主要内容
临床试验/IRCT201410271556N68
IRCT201410271556N68已完成2 期

Simvastatin versus Atorvastatin in the treatment of mild to moderate depression in post CABG patients: a double blind randomized clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 80 years(—)
性别
All

入选标准

  • 1. Patients who have undergone coronary bypass surgery.
  • 2. Patients who based on DSM-IV have major depression and based Hamilton rating scale for depression (Ham-D 17 items) their score is => 18.
  • 3. No psychiatric symptoms
  • 4. Not receiving psychotropic drugs
  • 5. Not receiving antidepressants during the last month
  • 6. Do not receiving ECT during the last two months
  • 7. No thyroid problem
  • 8. Age between 15 and 80 years
  • 9. No liver dysfunction
  • 10. No Muscular disorders
  • 11. Not receiving other antilipid drugs
  • 12. No hypersensitivity to statins
  • 13. LDL => 80
  • 14. Liver enzymes not being elevated at the time of recruitment
  • 15. No life threatening disease
  • 16. No neurological disorders
  • 17. Not being pregnant
  • 18. No breast feeding
  • 19. Giving informed consent
  • Exclusion criteria:
  • 1. Existing other disorders rather than depression, including Bipolar disorders, Schizophrenia, and other psychotic disorders
  • 2. History of drug abuse or dependency within the last three months
  • 3. Probability of suicide or its tendency during the last year
  • 4. Women who are going to be pregnant within the next few months
  • 5. Women who use OCP for pregnancy prevention
  • 6. Patients who have received antidepressants during the last month
  • 7. Patients who have received ECT withing the last two months
  • 8. Patients who need un-usual psychiatric treatments
  • 9. Patients with liver dysfunction
  • 10. Muscular disorders
  • 11. Receiving other antilipid drugs
  • 12. Hypersensitivity to statins
  • 13. LDL < 80
  • 14. Elevated liver enzymes at the time of recruitment
  • 15. Life threatening diseases
  • 16. Neurological diseases

排除标准

  • 未提供

研究者

相似试验